The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
January 22nd 2025
The FDA approved treosulfan, in combination with fludarabine, for patients 1 year of age and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Role of the Oncology Pharmacists Is ‘On the Cusp of Beginning to Evolve and Change’
January 26th 2024Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discusses the multifaceted role of oncology pharmacists in diverse care settings, emphasizing their collaboration in treatment decisions and adaption in the evolving landscape of cancer care.
Watch
Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population
Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.
Read More